Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ultralife (ULBI) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to 3.36%.

  • Ultralife's EBITDA Margin fell 63600.0% to 3.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.93%, marking a year-over-year decrease of 51700.0%. This contributed to the annual value of 3.63% for FY2024, which is 9700.0% down from last year.
  • Latest data reveals that Ultralife reported EBITDA Margin of 3.36% as of Q3 2025, which was down 63600.0% from 3.61% recorded in Q2 2025.
  • Over the past 5 years, Ultralife's EBITDA Margin peaked at 7.61% during Q4 2023, and registered a low of 3.36% during Q3 2025.
  • Moreover, its 4-year median value for EBITDA Margin was 3.38% (2021), whereas its average is 3.25%.
  • The largest annual percentage gain for Ultralife's EBITDA Margin in the last 5 years was 68100bps (2024), contrasted with its biggest fall of -92700bps (2024).
  • Over the past 4 years, Ultralife's EBITDA Margin (Quarter) stood at 3.38% in 2021, then skyrocketed by 125bps to 7.61% in 2023, then tumbled by -122bps to 1.66% in 2024, then tumbled by -102bps to 3.36% in 2025.
  • Its EBITDA Margin stands at 3.36% for Q3 2025, versus 3.61% for Q2 2025 and 4.29% for Q1 2025.